AMAG: AMAG Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 300.83
Enterprise Value ($M) 428.52
Book Value ($M) 614.72
Book Value / Share 18.12
Price / Book 0.49
NCAV ($M) -38.06
NCAV / Share -1.12
Price / NCAV -7.91

Profitability (mra)
Return on Invested Capital (ROIC) -0.06
Return on Assets (ROA) -0.04
Return on Equity (ROE) -0.08

Liquidity (mrq)
Quick Ratio 2.13
Current Ratio 2.30

Balance Sheet (mrq) ($M)
Current Assets 420.07
Assets 1,072.85
Liabilities 458.13
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -303.84
Net Income -65.76
Earnings Per Share Basic And Diluted 0.00
Earnings Per Share Diluted -1.91
Earnings Per Share Basic -1.91

Cash Flow Statement (mra) ($M)
Cash From Operations 60.80
Cash from Investing 502.15
Cash from Financing 502.15

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-02-14 13G/A Armistice Capital, Llc 12.70 7.50
2020-02-14 13G/A Palo Alto Investors, LLC
2020-02-13 13G State Street Corp 8.00 5.01
2020-02-12 13G Renaissance Technologies LLC 5.99
2020-02-12 13G/A Vanguard Group Inc 8.33 -19.75
2020-02-04 13G/A BlackRock Inc. 16.40 1.79
2020-01-31 13G Goldman Sachs Group Inc 6.10
2019-10-15 13G Camber Capital Management LLC
2019-10-10 13D/A Caligan Partners Lp 10.40 0.57
2019-04-08 13G/A Jackson Square Partners, LLC 0.26 -96.95
2018-02-13 13G/A FMR LLC / Fidelity 4.64 -23.66
2018-02-06 13G/A Janus Capital Management Llc 0.00 -99.92
2017-02-14 13G/A Point72 Asset Management, L.P. 0.40 -92.66
2017-02-14 13G/A D. E. Shaw & Co, L.p. 3.10 -39.02
2017-02-10 13G/A Westfield Capital Management Co Lp 0.00 -100.00
2017-02-09 13G/A Adage Capital Partners GP LLC 0.86 -88.73
2016-06-10 13G/A Putnam Investments Llc 1.50 -86.25
2015-02-17 13G/A Broadfin Capital, LLC 2.60
2015-02-17 13G/A Flynn James E 0.00
2015-02-12 13G/A Price T Rowe Associates Inc /md/ 1.70
2015-02-12 13G/A Visium Asset Management, LP 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2019-11-01 10-Q AMAG / AMAG Pharmaceuticals, Inc. 10-Q – Quarterly Report – 10-Q
2019-08-07 10-Q AMAG / AMAG Pharmaceuticals, Inc. 10-Q – Quarterly Report – 10-Q
2019-05-08 10-Q AMAG / AMAG Pharmaceuticals, Inc. 10-Q Quarterly Report 10-Q
2019-03-01 10-K AMAG / AMAG Pharmaceuticals, Inc. 10-K (Annual Report)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-02-18 90,961 395,000 23.03
2020-02-14 125,559 447,300 28.07
2020-02-13 66,882 462,400 14.46

(click for more detail)

Similar Companies
ALT – Altimmune, Inc. ALXA – Alexza Pharmaceuticals, Inc.
ALXN – Alexion Pharmaceuticals, Inc. AMBI – Ambit Biosciences Corp
AMGN – Amgen Inc.


Financial data and stock pages provided by
Fintel.io